Asuragen, Inc. Appoints Lyle Arnold, Ph.D., to Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a leader in molecular diagnostic development, announced today the appointment of Lyle Arnold, Ph.D., to its board of directors.

MORE ON THIS TOPIC